{
    "clinical_study": {
        "@rank": "164771", 
        "arm_group": {
            "arm_group_label": "Dovitinib monotherapy", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Efficacy of Dovitinib for Squamous NSCLC."
        }, 
        "brief_title": "Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer", 
        "condition": "Squamous NSCLC", 
        "condition_browse": {
            "mesh_term": "Carcinoma, Non-Small-Cell Lung"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  histologically confirmed squamous NSCLC\n\n          -  Previously treated with one or two lines of chemotherapy\n\n          -  FGFR amplification (FISH > 5 copies of genes)\n\n          -  20 years or older\n\n          -  ECOG PS 0-2\n\n        Exclusion Criteria:\n\n          -  active infection\n\n          -  uncontrolled brain metastasis\n\n          -  unstable angina or MI"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "27", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01861197", 
            "org_study_id": "2012-09-070-002"
        }, 
        "intervention": {
            "arm_group_label": "Dovitinib monotherapy", 
            "description": "Dovitinib 500mg daily for 5 days on/ 2 day off until progression", 
            "intervention_name": "Dovitinib", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Efficacy", 
            "Dovitinib", 
            "Squamous NSCLC"
        ], 
        "lastchanged_date": "May 22, 2013", 
        "location": {
            "contact": {
                "email": "silkahn@skku.edu", 
                "last_name": "Myung-Ju Ahn, Ph.D.", 
                "phone": "822-3410-3459"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "135-710"
                }, 
                "name": "Samsung Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "silkahn@skku.edu", 
            "last_name": "Myung-Ju Ahn", 
            "phone": "822-3410-3459"
        }, 
        "overall_official": {
            "affiliation": "Samsung Medical Center", 
            "last_name": "Myung-Ju Ahn", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "response rate", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01861197"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Samsung Medical Center", 
            "investigator_full_name": "Myung-Ju Ahn", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Samsung Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}